Ordinary Index Rebalancing in the Solactive Transatlantic Healthcare Equity Index | July 2020

In the ordinary rebalance the following composition will be implemented effective open 08.07.2020:

ABBVIE INC
AGILENT TECHNOLOGIES INC
ALCON INC
ALEXION PHARMACEUTICALS INC
AMGEN INC
BAXTER INTL.
BECTON DICKINSON AND CO
BIO-RAD LABORATORIES INC
BIO-TECHNE CORP
BRISTOL-MYERS SQUIBB CO
CHINA BIOLOGIC PRODUCTS HOLD
CHR HANSEN HOLDING AS
COLOPLAST AS CLASS B
CONVATEC GROUP PLC
DANAHER CORP
DEMANT A/S
ESSILORLUXOTTICA
EUROFINS SCIENTIFIC SE
EVOTEC SE
FORMA THERAPEUTICS HOLDINGS INC
FRESENIUS MEDICAL CARE AG & CO KGAA
FRESENIUS SE & CO KGAA
GENMAB A/S
GETINGE AB CLASS B
GRIFOLS SA CLASS A
HIKMA PHARMACEUTICALS PLC
INCYTE CORP
JOHNSON & JOHNSON
KONINKLIJKE PHILIPS NV
LONZA GROUP AG
MASIMO CORPORATION
MERCK & CO. INC.
MERCK KGAA
NOVARTIS AG
NOVO NORDISK A/S
NOVOZYMES AS CLASS B
ORION OYJ CLASS B
PERKINELMER INC
PFIZER INC
QIAGEN NV
ROCHE HOLDING AG
SANOFI SA
SARTORIUS AG PREF
SIEMENS HEALTHINEERS AG
SONOVA HOLDING AG
SWEDISH ORPHAN BIOVITRUM AB
TECAN GROUP AG-REG
THERMO FISHER SCIENTIFIC INC
WEST PHARMACEUTICAL SERVICES INC
WRIGHT MEDICAL GROUP NV